Olema Pharmaceuticals inc (OLMA)
9.83
+0.17
(+1.76%)
USD |
NASDAQ |
May 17, 16:00
9.83
0.00 (0.00%)
Pre-Market: 20:00
Olema Pharmaceuticals Shareholders Equity (Quarterly): 236.32M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 236.32M |
| December 31, 2023 | 253.90M |
| September 30, 2023 | 275.13M |
| June 30, 2023 | 161.58M |
| March 31, 2023 | 174.98M |
| December 31, 2022 | 197.55M |
| September 30, 2022 | 217.70M |
| June 30, 2022 | 236.28M |
| Date | Value |
|---|---|
| March 31, 2022 | 265.09M |
| December 31, 2021 | 284.57M |
| September 30, 2021 | 300.89M |
| June 30, 2021 | 314.08M |
| March 31, 2021 | 326.02M |
| December 31, 2020 | 338.14M |
| September 30, 2020 | 125.41M |
| December 31, 2019 | -10.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.59M
Minimum
Dec 2019
338.14M
Maximum
Dec 2020
231.07M
Average
245.11M
Median
Shareholders Equity (Quarterly) Benchmarks
| Geron Corp | 344.87M |
| Verastem Inc | 46.22M |
| Fate Therapeutics Inc | 426.12M |
| Karyopharm Therapeutics Inc | -168.96M |
| Alpine Immune Sciences Inc | 332.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 263.69M |
| Total Liabilities (Quarterly) | 27.38M |